Thus, we decided to administer the human IPF-ABCs or HV-ABCs three days after causing the lung minimal injury with a low dose of bleomycin to RAG2−/− mice (1.2 mg/Kg body weight IT, Fig. 3a). Here, RAG2 is linked to idiopathic pulmonary fibrosis.